Apollo Hospitals Share Price Rises 4%; PAT Rises 35% in Q3 FY26 Results

Apollo Hospitals Enterprise Ltd reported consolidated performance for the quarter ended December 31, 2025. 

Apollo Hospitals Q3 FY26 Financial Performance

Overall consolidated revenue rose 17% year-on-year to ₹64,774 million, supported by steady growth across healthcare services, diagnostics, retail health, digital health, and pharmacy distribution segments. 

EBITDA increased 27% to ₹9,653 million, reflecting operational efficiency and improved margins across businesses. 

Consolidated Profit After Tax (PAT) grew 35% year-on-year to ₹5,023 million, indicating robust profitability improvement over the same period last year.

Segment-wise, Healthcare Services generated revenue of ₹31,832 million, while Diagnostics and Retail Health contributed ₹4,668 million. Digital Health and Pharmacy Distribution together delivered revenue of ₹28,274 million, supporting overall consolidated growth. 

Reported PAT contributions stood at ₹4,219 million from Healthcare Services and ₹866 million from Digital Health and Pharmacy Distribution, partially offset by a marginal loss in Diagnostics and Retail Health.

In comparison, during Q3 FY25, consolidated revenue stood at ₹55,269 million and PAT was ₹3,723 million, highlighting year-on-year improvement across segments.

Performance for Nine Months Ended December 2025

For the nine months ended December 2025, consolidated revenue increased 15% year-on-year to ₹186,230 million. 

EBITDA rose 22% to ₹27,584 million, supported by healthy growth across hospital services and pharmacy distribution operations. 

Consolidated PAT grew 34% to ₹14,123 million, underlining consistent profitability expansion during the financial year so far.

The continued expansion in healthcare demand, stronger pharmacy distribution performance, and digital health adoption have helped drive sustained financial momentum.

Apollo Hospitals Share Price Performance

On February 11, 2026, Apollo Hospitals share price (NSE: APOLLOHOSP) opened at ₹7,405.00, up from its previous close of ₹7,219.00. At 10:42 AM, the share price of Apollo Hospitals was trading at ₹7,545, up by 4.52% on the NSE.

Also Read: Apollo Hospitals Gets CCI Nod to Acquire 30.58% Stake in Apollo Health!

Conclusion

Apollo Hospitals delivered a strong Q3 FY26 performance, supported by growth across its core healthcare services and pharmacy distribution businesses. With continued expansion in healthcare demand and operational efficiencies, the company remains well-positioned for sustained growth in the coming quarters.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.